4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects.

Liao ST, Han C, Xu DQ, Fu XW, Wang JS, Kong LY. · 2019

Read 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects. by Liao ST, Han C, Xu DQ, Fu XW, Wang JS, Kong LY. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6841710.txt.

Description

Liao and co-authors report a study in Nature Communications on an inflammation-calming compound. When macrophages switch on, they change how they make energy, favouring fast sugar burning called aerobic glycolysis. That switch fuels their attack mode. A natural metabolite, itaconate, reins them in. The team used a form that enters cells, 4-octyl itaconate, to find out how.

The compound latched onto the glycolysis enzyme GAPDH at one spot, cysteine residue 22, and cut its activity. Sugar tracing showed the flow of glycolysis blocked at that step. With glycolysis curbed, inflammatory output fell. Other glycolysis blockers copied the effect. The result names a precise lever for calming harmful inflammation.

Catalog record

CREATORLiao ST, Han C, Xu DQ, Fu XW, Wang JS, Kong LY.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE53 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6841710

Browse the full library · About the Tower of Babel